Drug intelligence / Profile preview

undenatured type II collagen

Development stage
Unknown
Lead developer
Lonza
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Undenatured type II collagen is a biologically active form of type II collagen derived chiefly from chicken sternum cartilage using a patented low-temperature process that preserves its natural triple-helix structure. It is distinct from hydrolyzed/denatured collagen in that the native protein epitopes remain intact. Orally administered undenatured type II collagen interacts with the gut-associated lymphoid tissue (Peyer’s patches) to induce antigen-specific oral tolerance, where it transforms naïve T cells into regulatory T cells that then downregulate autoimmune responses against joint cartilage. This immunomodulatory mechanism leads to reduced inflammation and may protect and repair cartilage in conditions like osteoarthritis and, to a lesser extent, rheumatoid arthritis. Clinical and preclinical data mainly support its use as a dietary supplement for joint health, especially in osteoarthritis.

Brand names
UC-IINEXT-II
Other names
native type II collagenUC-II collagenundenatured collagen type II
02

Targets

MHC II (Major histocompatibility complex class II receptor)

Beyond the preview

Go deeper on undenatured type II collagen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on undenatured type II collagen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call